rs4636

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_182972.3(IRF2BP2):​c.828G>T​(p.Ala276Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 1,521,876 control chromosomes in the GnomAD database, including 94,643 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7665 hom., cov: 33)
Exomes 𝑓: 0.35 ( 86978 hom. )

Consequence

IRF2BP2
NM_182972.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.425

Publications

12 publications found
Variant links:
Genes affected
IRF2BP2 (HGNC:21729): (interferon regulatory factor 2 binding protein 2) This gene encodes an interferon regulatory factor-2 (IRF2) binding protein that interacts with the C-terminal transcriptional repression domain of IRF2. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2008]
IRF2BP2 Gene-Disease associations (from GenCC):
  • immunodeficiency, common variable, 14
    Inheritance: AD, Unknown Classification: LIMITED Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 1-234608667-C-A is Benign according to our data. Variant chr1-234608667-C-A is described in ClinVar as Benign. ClinVar VariationId is 402983.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.425 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.358 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
IRF2BP2NM_182972.3 linkc.828G>T p.Ala276Ala synonymous_variant Exon 1 of 2 ENST00000366609.4 NP_892017.2
IRF2BP2NM_001077397.1 linkc.828G>T p.Ala276Ala synonymous_variant Exon 1 of 2 NP_001070865.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
IRF2BP2ENST00000366609.4 linkc.828G>T p.Ala276Ala synonymous_variant Exon 1 of 2 1 NM_182972.3 ENSP00000355568.3
IRF2BP2ENST00000366610.8 linkc.828G>T p.Ala276Ala synonymous_variant Exon 1 of 2 1 ENSP00000355569.3
ENSG00000228830ENST00000436039.1 linkn.631-754C>A intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.303
AC:
46099
AN:
152042
Hom.:
7666
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.180
Gnomad AMI
AF:
0.313
Gnomad AMR
AF:
0.334
Gnomad ASJ
AF:
0.424
Gnomad EAS
AF:
0.220
Gnomad SAS
AF:
0.267
Gnomad FIN
AF:
0.373
Gnomad MID
AF:
0.363
Gnomad NFE
AF:
0.362
Gnomad OTH
AF:
0.332
GnomAD2 exomes
AF:
0.356
AC:
46831
AN:
131388
AF XY:
0.358
show subpopulations
Gnomad AFR exome
AF:
0.215
Gnomad AMR exome
AF:
0.304
Gnomad ASJ exome
AF:
0.436
Gnomad EAS exome
AF:
0.257
Gnomad FIN exome
AF:
0.393
Gnomad NFE exome
AF:
0.401
Gnomad OTH exome
AF:
0.387
GnomAD4 exome
AF:
0.352
AC:
482618
AN:
1369716
Hom.:
86978
Cov.:
37
AF XY:
0.351
AC XY:
237540
AN XY:
677110
show subpopulations
African (AFR)
AF:
0.175
AC:
4886
AN:
27930
American (AMR)
AF:
0.299
AC:
9793
AN:
32804
Ashkenazi Jewish (ASJ)
AF:
0.419
AC:
9860
AN:
23514
East Asian (EAS)
AF:
0.243
AC:
8017
AN:
32968
South Asian (SAS)
AF:
0.282
AC:
21506
AN:
76374
European-Finnish (FIN)
AF:
0.365
AC:
13963
AN:
38230
Middle Eastern (MID)
AF:
0.386
AC:
1755
AN:
4546
European-Non Finnish (NFE)
AF:
0.365
AC:
393001
AN:
1076562
Other (OTH)
AF:
0.349
AC:
19837
AN:
56788
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
18584
37169
55753
74338
92922
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
12432
24864
37296
49728
62160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.303
AC:
46106
AN:
152160
Hom.:
7665
Cov.:
33
AF XY:
0.305
AC XY:
22683
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.180
AC:
7470
AN:
41538
American (AMR)
AF:
0.334
AC:
5103
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.424
AC:
1471
AN:
3468
East Asian (EAS)
AF:
0.220
AC:
1139
AN:
5176
South Asian (SAS)
AF:
0.267
AC:
1292
AN:
4832
European-Finnish (FIN)
AF:
0.373
AC:
3949
AN:
10586
Middle Eastern (MID)
AF:
0.366
AC:
107
AN:
292
European-Non Finnish (NFE)
AF:
0.362
AC:
24588
AN:
67954
Other (OTH)
AF:
0.332
AC:
702
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1618
3235
4853
6470
8088
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
454
908
1362
1816
2270
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.334
Hom.:
1574
Bravo
AF:
0.297
Asia WGS
AF:
0.247
AC:
860
AN:
3474

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Jan 24, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 47% of patients studied by a panel of primary immunodeficiencies. Number of patients: 45. Only high quality variants are reported. -

Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Immunodeficiency, common variable, 14 Benign:1
Aug 19, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
9.6
DANN
Benign
0.91
PhyloP100
-0.42
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4636; hg19: chr1-234744413; COSMIC: COSV64014518; COSMIC: COSV64014518; API